Portfolio company
Ardian
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops medical devices for catheter-based renal denervation to treat hypertension in patients with high blood pressure.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ReCor Medical
This medical technology company develops ultrasound renal denervation systems for clinicians treating patients with uncontrolled or resistant hypertension.
Mineralys Therapeutics
The company develops an aldosterone synthase inhibitor medicine to treat patients with uncontrolled or treatment-resistant hypertension and chronic kidney disease.
Mineralys
This biopharmaceutical company develops aldosterone synthase inhibitors to treat patients with uncontrolled hypertension and related cardio-renal-metabolic diseases.
Aria CV, Inc
This medical technology company develops an implantable balloon system to treat pulmonary arterial hypertension by restoring vessel compliance and reducing cardiac workload.
preCARDIA
This company develops catheter-based systems for heart failure specialists to treat patients suffering from acute decompensated heart failure and volume overload.
CVRx
This company develops implantable neuromodulation devices that stimulate the baroreflex to treat heart failure and hypertension for clinical institutions and their patients.
ENDOVASCULAR DEVICES
This company develops minimally invasive vessel preparation tools to treat peripheral artery disease and failed arteriovenous fistulas for interventional clinicians.
SoniVie
SoniVie develops ultrasound-based intravascular denervation systems to treat patients with hypertensive disorders, including resistant hypertension and pulmonary arterial hypertension.